Ispire's Q3 earnings report reveals massive growth

May.17.2023
Ispire's Q3 earnings report reveals massive growth
Ispire released Q3 2023 financial report with impressive YoY revenue growth of 26.9% and gross profit growth of 51.9%.

On May 16th, Ispire announced the release of their financial report for the third quarter of 2023, ending on March 31st. The company also submitted their 10-Q quarterly report to the US Securities and Exchange Commission (SEC) on May 15th. According to the report, Ispire saw a year-over-year revenue growth of 26.9%, reaching $24.1 million in the third quarter, while their gross profit increased by 51.9% to $4.5 million.


It's worth noting that the company's fiscal year end is on June 30, 2023, and they have not chosen December 31 as their fiscal year end date.


Rise in Cannabis Smoking Accessories Sales is a Popular Betting Trend


Michael Wang, the Chief Financial Officer of Ispire, has stated that the company is expecting a continuous revenue growth of 58% to 98% in the fourth quarter of their marijuana smoking devices products.


He added:


We are focused on a multi-pronged strategy aimed at increasing sales of our electronic cigarette products and developing CBD vaporization products with an emphasis on medical and recreational use.


Third Quarter Performance: Tobacco vaporization remains the main product.


In the third quarter of 2023, Ispire recorded a year-on-year revenue growth of 26.9%, reaching $24.1 million. The revenue contribution of electronic cigarette products was $16.5 million, while that of CBD-related vaporizer products was $7.6 million. Gross profit grew 51.9% year-on-year to $4.5 million. However, total operating expenses increased by 106.2% YoY, reaching $8 million compared to $3.9 million in the same period of 2022. Net loss amounted to $3.1 million, whereas in the same period of 2022, the net loss was $1 million.


Looking ahead to the future.


Ispire has provided a projection for its CBD vaporization products for the fourth quarter of 2023 (ending June 30, 2023). The company began marketing CBD vaporization products in mid-2020, with revenue reaching $7.6 million in the third quarter of 2023. It is expected that the revenue in the fourth quarter of 2023 for CBD vaporization products will increase by 58% to 98% compared to the third quarter, with projected revenue ranging between $12 million to $15 million.


According to reports, Ispire is a company that specializes in research and development, design, commercialization, sales, promotion, and distribution of branded electronic cigarettes and CBD vaporization products. The company's tobacco electronic cigarette products are sold under the Aspire brand name.


References:


Ispire Technology Inc. has released its financial results for the third quarter of 2023.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
A meeting was held at the Department for Combating Economic Crimes under the General Prosecutor’s Office of Uzbekistan with representatives of British American Tobacco Uzbekistan. Participants included the department’s leadership, the Inspectorate for Regulation of the Alcohol and Tobacco Market, and business representatives.
May.09 by 2FIRSTS.ai
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Mykhailo Radutskyi, chair of the Verkhovna Rada Committee on National Health, Medical Assistance and Medical Insurance, said nicotine pouches should be fully banned for sale to minors and their advertising should be restricted.
Apr.07 by 2FIRSTS.ai
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
State Attorneys General Urge Visa, Mastercard and Others to Stop Processing Illicit E-Cigarette Transactions
State Attorneys General Urge Visa, Mastercard and Others to Stop Processing Illicit E-Cigarette Transactions
Fourteen U.S. state attorneys general sent a joint letter dated April 14, 2026 to Visa, Mastercard, American Express and Discover, asking them to immediately help stop the sale of illicit e-cigarette products by cutting off payment access.
Apr.17 by 2FIRSTS.ai
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20